Ovid Therapeutics Inc. (OVID) has 20 known insider and institutional holders on record. The largest holder is TAKEDA PHARMACEUTICAL CO LTD with 5,750,000 shares. Other notable holders include LEVIN JEREMY M and Werber Yaron.
Over the last 12 months, insiders have made 19 transactions in OVID stock — 14 buys (valued at $6.15M) and 2 sells (valued at $29.29K). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.
OVID Insider Ownership
Top Holder
TAKEDA PHARMACEUTICAL CO LTD
5,750,000 shares
Buys (12 mo)
14
$6.15M value
Sells (12 mo)
2
$29.29K value
12-Month Transaction Activity
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Takeda Pharmaceutical Co Ltd |
10 Percent Owner |
5,750,000 |
2019-11-22 |
|
| 2 |
Levin Jeremy M |
Director |
957,000 |
2026-03-02 |
|
| 3 |
Werber Yaron |
Cbo, CFO, Sec. and Treas. |
131,000 |
2018-01-23 |
|
| 4 |
Daly Timothy |
EVP,finance & Corp. Controller |
125,000 |
2020-12-21 |
|
| 5 |
Haasner Dirk |
SVP, Global Regulatory Affairs |
100,000 |
2020-12-21 |
|
| 6 |
Rakhit Amit |
President and CMO |
90,983 |
2021-07-16 |
|
| 7 |
Rona Jeffrey A |
Cbfo |
88,188 |
2026-03-02 |
|
| 8 |
During Matthew |
10 Percent Owner |
75,000 |
2019-04-03 |
|
| 9 |
Duncan Barbara Gayle |
Director |
65,000 |
2026-03-02 |
|
| 10 |
Fitzgerald Kevin Joseph |
Director |
65,000 |
2026-03-02 |
|
| 11 |
Bernstein Karen |
Director |
65,000 |
2026-03-02 |
|
| 12 |
Papadopoulos Stelios |
Director |
65,000 |
2026-03-02 |
|
| 13 |
Friedman Bart |
Director |
65,000 |
2026-03-02 |
|
| 14 |
Alexander Margaret A. |
President and CEO |
61,750 |
2026-03-02 |
|
| 15 |
Ward Ana |
SVP and General Counsel |
40,000 |
2019-02-26 |
|
| 16 |
Poole Robert Michael |
Director |
30,000 |
2024-02-26 |
|
| 17 |
Tardio Jason |
Chief Operating Officer |
28,125 |
2024-02-26 |
|
| 18 |
Perone Thomas Michael |
General Counsel, Secretary |
28,125 |
2024-02-26 |
|
| 19 |
Williams Douglas E |
Director |
1,750 |
2021-05-18 |
|
| 20 |
Takeda Pharmaceuticals U.s.a., Inc. |
Director |
1,250 |
2022-07-06 |
|
Recent Transactions (last 12 months)
| Date |
Name |
Role |
Type |
Shares |
Price |
Value |
| 2026-03-23 |
Levin Jeremy M |
Executive Chairman |
Option Exercise (Sell) |
47,333 |
$1.40 |
$66.27K |
| 2026-02-26 |
Alexander Margaret A. |
President and CEO |
RSU Award |
1,435,000 |
$1.65 |
$2.37M |
| 2026-02-23 |
Alexander Margaret A. |
President and CEO |
Informative Sell |
11,656 |
$1.45 |
$16.9K |
| 2026-02-26 |
Fitzgerald Kevin Joseph |
Director |
RSU Award |
65,000 |
$1.65 |
$107.25K |
| 2026-02-26 |
Bernstein Karen |
Director |
RSU Award |
65,000 |
$1.65 |
$107.25K |
| 2026-02-26 |
Friedman Bart |
Director |
RSU Award |
65,000 |
$1.65 |
$107.25K |
| 2026-02-26 |
Duncan Barbara Gayle |
Director |
RSU Award |
65,000 |
$1.65 |
$107.25K |
| 2026-02-26 |
Rona Jeffrey A |
Cbfo |
RSU Award |
68,125 |
- |
- |
| 2026-02-23 |
Rona Jeffrey A |
Cbfo |
Informative Sell |
8,541 |
$1.45 |
$12.38K |
| 2026-02-26 |
Levin Jeremy M |
Director |
RSU Award |
957,000 |
$1.65 |
$1.58M |
| 2026-02-26 |
Papadopoulos Stelios |
Director |
RSU Award |
65,000 |
$1.65 |
$107.25K |
| 2026-01-04 |
Alexander Margaret A. |
President and CEO |
RSU Award |
890,000 |
$1.76 |
$1.57M |
| 2025-12-15 |
Levin Jeremy M |
CEO |
Conversion (Sell) |
71 |
- |
- |
| 2025-12-11 |
Levin Jeremy M |
CEO |
Informative Buy |
71 |
- |
- |
| 2025-12-08 |
Takeda Pharmaceutical Co Ltd |
10 Percent Owner |
Conversion (Sell) |
1,250 |
- |
- |
| 2025-02-20 |
Fitzgerald Kevin Joseph |
Director |
RSU Award |
45,000 |
$0.57 |
$25.65K |
| 2025-02-20 |
Bernstein Karen |
Director |
RSU Award |
45,000 |
$0.57 |
$25.65K |
| 2025-02-20 |
Friedman Bart |
Director |
RSU Award |
45,000 |
$0.57 |
$25.65K |
| 2025-02-20 |
Duncan Barbara Gayle |
Director |
RSU Award |
45,000 |
$0.57 |
$25.65K |
